Rami Nasr

Dr. Rami Nasr


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2014 in BMC Urology
Verified
Journal Article
Open access
PDF file
Sally TemrazSally Temraz
Sally Temraz
DMDeborah Mukherji
Deborah Mukherji
ZFZein Al Abideen Farhat
Zein Al Abideen Farhat
RNRami Nasr
Rami Nasr
MCMaya Charafeddine
Maya Charafeddine
Ali ShamseddineAli Shamseddine
Ali Shamseddine
Inflammation is a critical component of tumorigenesis, and many cancers arise from sites of infection, chronic irritation, and inflammation. Inflammatory cytokines triggered by tumors alter hematologic components, including neutrophil, lymphocyte, and monocyte counts. The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios have been shown to be valuable prognostic markers in various types of cancers, including bladder cancer. Risk stratification based on clinicopathologic data is insufficient to support treatment-related choices in patients with bladder cancer. Novel prognostic markers are therefore needed. An elevated pretreatment lymphocyte-to-monocyte ratio (LMR) is reportedly associated with improved overall survival (OS) and a longer time to treatment recurrence (TTR) in some types of cancers. However, these data are lacking in patients with bladder cancer. The aim of the present study was to investigate the effect of the preoperative LMR on OS and TTR in a cohort of patients with bladder cancer.

8 November 2019 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
NHNassib Abou Heidar
Nassib Abou Heidar
MLMuhieddine Labban
Muhieddine Labban
GBGerges Bustros
Gerges Bustros
RNRami Nasr
Rami Nasr

26 December 2019 in Case Reports in Pathology
Verified
Journal Article
Open access
PDF file
JDJad A. Degheili
Jad A. Degheili
NHNassib Abou Heidar
Nassib Abou Heidar
MEMouhammad El-Moussawi
Mouhammad El-Moussawi
ATAyman Tawil
Ayman Tawil
RNRami Nasr
Rami Nasr
Cavernous hemangiomas are endothelial tumors that rarely affect the adrenal glands. Most of these tumors remain silent and are incidentally found on abdominal imaging. Hardly ever, these tumors are endocrinologically functional. They may present as vague abdominal pain. Surgical resection remains the mainstay for large masses. In this paper, we are presenting a case of adrenal cavernous hemangioma in a 83-year-old male patient who initially presented for workup of vague abdominal and bilateral flank pain. A computed tomography scan of the abdomen showed an 8 cm right adrenal adenoma which was metabolically nonfunctional. The mass was completely resected through an open subcostal incision, with no encountered postoperative complications. A highlight of all published cases of adrenal hemangiomas since 1955 is also presented and reviewed.

1 March 2022 in Urology Research and Practice
Verified
Journal Article
Open access
AEAdnan El-Achkar
Adnan El-Achkar
NHNassib Abou Heidar
Nassib Abou Heidar
MLMuheiddine Labban
Muheiddine Labban
MAMouhamad Al-Moussawy
Mouhamad Al-Moussawy
HMHisham Moukaddem
Hisham Moukaddem
RNRami Nasr
Rami Nasr
Objective: To report on the outcomes of transperineal versus transrectal magnetic resonance imaging/ultrasound fusion biopsy of the prostate including detection of clinically significant cancer and complications. This is the first and largest series in the Middle East. Material and methods: Between May 2019 and June 2020, 145 patients with suspicious lesions on magnetic resonance imaging underwent magnetic resonance imaging/ultrasound fusion prostate biopsy at our center. Transperineal biopsy was performed under light sedation, while transrectal biopsy patients had a periprostatic block for anesthesia. Clinically significant cancer was defined as Gleason ≥3+4 Results: In all, 98 transperineal biopsies and 47 transrectal magnetic resonance imaging/ultrasound fusion prostate biopsies were done. Patients had similar prebiopsy parameters (transperineal vs. transrectal): median age (64.5 vs. 66 years; P=.68), median prostate-specific antigen value (7.5 vs. 7.5; P=.42), and median prostate volume (51 vs. 52.5; P=.83). Those that underwent transperineal biopsy had fewer average total number of cores compared to transrectal ultrasound-guided biopsy (11 vs. 13; P=.025) fewer average number of random cores (3 vs. 6; P < .0001), and the detection rate of clinically significant cancer was similar between the groups (44% vs. 48.9%; P=.57). No difference in hematuria, retention, and sepsis rate requiring admission (1 vs. 2; P=.2) was observed. However, more patients had urinary tract infection in the transrectal ultrasound-guided biopsy group compared to transperineal biopsy group (5 vs. 1; P=.006) that were treated with antibiotics on outside basis. Conclusion: Magnetic resonance imaging/ultrasound transperineal fusion biopsy has similar detection rate of clinically significant cancer compared to transrectal ultrasound-guided biopsy with less urinary tract infection post biopsy. Cite this article as: El-Achkar A, Abou Heidar N, Labban M, et al. MRI/US fusion transperineal versus transrectral biopsy of prostate cancer: Outcomes and complication rates, a tertiary medical center experience in the middle east. Turk J Urol. 2022;48(2):98-105.

29 June 2021 in Canadian Urological Association Journal
Verified
Journal Article
Closed access
PDF file
NHNassib Abou Heidar
Nassib Abou Heidar
MLMuhieddine Labban
Muhieddine Labban
DNDavid-Dan Nguyen
David-Dan Nguyen
AEAdnan El-Achkar
Adnan El-Achkar
MMMazen Mansour
Mazen Mansour
RNRami Nasr
Rami Nasr
Introduction: Recent studies have shown that software-generated 3D stone volume calculations are better predictors of stone burden than measured maximal axial stone diameter. However, no studies have assessed the role of formula estimated stone volume, a more practical and cheaper alternative to software calculations, to predict spontaneous stone passage (SSP). Methods: We retrospectively included patients discharged from our emergency department on conservative treatment for ureteral stone (≤10 mm). We collected patient demographics, comorbidities, and laboratory tests. Using non-contrast computed tomography (CT) reports, stone width, length, and depth (w, l, d, respectively) were used to estimate stone volumes using the ellipsoid formula: V=π*l*w*d*0.167. Using a backward conditional regression, two models were developed incorporating either estimated stone volume or maximal axial stone diameter. A receiver operator characteristic (ROC) curve was constructed and the area under the curve (AUC) was computed and compared to the other model. Results: We included 450 patients; 243 patients (54%) had SSP and 207 patients (46%) failed SSP. The median calculated stone volume was significantly smaller among patients with SSP: 25 (14–60) mm3 vs. 113 (66–180) mm3 (p75 (OR 4.83, 95% CI 2.12–11.00), and proximal stone (OR 2.11, 95% CI 1.16–3.83). For every 1 mm3 increase in stone volume, the risk of SSP failure increased by 2.5%. The model explained 89.4% (0.864–0.923) of the variability in the outcome. This model was superior to the model including maximal axial diameter (0.881, 0.847–0.909, p=0.04). Conclusions: We present a nomogram incorporating stone volume to better predict SSP. Stone volume estimated using an ellipsoid formula can predict SSP better than maximal axial diameter.

13 February 2018 in Case Reports in Urology
Verified
Journal Article
Open access
PDF file
JDJad A. Degheili
Jad A. Degheili
MMMazen M. Mansour
Mazen M. Mansour
RNRami Nasr
Rami Nasr
Prostate cancer is the most common solid cancer among American men. Although there are various modalities for treatment, including radical prostatectomy among many others, the former is, nevertheless, not without any accompanied complications. Other than the well-known surgical complications such as erectile dysfunction, urinary incontinence, and voiding dysfunction, osteomyelitis of the symphysis pubis is not a well-understood complication, with various hypotheses explaining its pathogenesis. Although osteomyelitis of the pubis symphysis has been reported after endoscopic urological procedures such as transurethral resection of the prostate, it has rarely been reported after robotic surgeries. We hereby report, to the best of our knowledge, the first osteomyelitis of the pubis symphysis, after robotic prostatectomy, in a patient with prostate cancer and no previous radiation therapy.